Page last updated: 2024-09-04

nepafenac and Retinal Neovascularization

nepafenac has been researched along with Retinal Neovascularization in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bingaman, DP; Clark, ML; Penn, JS; Yang, R; Yanni, SE	1
Ando, A; Bingaman, DP; Campochiaro, PA; Melia, MB; Mori, K; Nambu, H; Oshima, Y; Saishin, Y; Takahashi, K; Yamamoto, S	1

Other Studies

2 other study(ies) available for nepafenac and Retinal Neovascularization

Article	Year
The effects of nepafenac and amfenac on retinal angiogenesis. Brain research bulletin, 2010, Feb-15, Volume: 81, Issue:2-3 Topics: Analysis of Variance; Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Celecoxib; Cell Proliferation; Cyclooxygenase Inhibitors; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Epithelial Cells; Gene Expression Regulation; Humans; Neuroglia; Oxygen; Phenylacetates; Prostaglandins; Pyrazoles; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Retina; Retinal Neovascularization; Retinal Vessels; Sulfonamides; Vascular Endothelial Growth Factor A	2010
Topical nepafenac inhibits ocular neovascularization. Investigative ophthalmology & visual science, 2003, Volume: 44, Issue:1 Topics: Administration, Topical; Animals; Benzeneacetamides; Choroidal Neovascularization; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Endothelial Growth Factors; Intercellular Signaling Peptides and Proteins; Isoenzymes; Ketorolac Tromethamine; Lymphokines; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Ophthalmic Solutions; Phenylacetates; Prodrugs; Prostaglandin-Endoperoxide Synthases; Retinal Neovascularization; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2003

Article

Year

The effects of nepafenac and amfenac on retinal angiogenesis.

Brain research bulletin, 2010, Feb-15, Volume: 81, Issue:2-3

Topics: Analysis of Variance; Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Celecoxib; Cell Proliferation; Cyclooxygenase Inhibitors; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Epithelial Cells; Gene Expression Regulation; Humans; Neuroglia; Oxygen; Phenylacetates; Prostaglandins; Pyrazoles; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Retina; Retinal Neovascularization; Retinal Vessels; Sulfonamides; Vascular Endothelial Growth Factor A

2010

Topical nepafenac inhibits ocular neovascularization.

Investigative ophthalmology & visual science, 2003, Volume: 44, Issue:1

Topics: Administration, Topical; Animals; Benzeneacetamides; Choroidal Neovascularization; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Endothelial Growth Factors; Intercellular Signaling Peptides and Proteins; Isoenzymes; Ketorolac Tromethamine; Lymphokines; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Ophthalmic Solutions; Phenylacetates; Prodrugs; Prostaglandin-Endoperoxide Synthases; Retinal Neovascularization; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2003